Drugs / Fecal Microbial Transplants
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04150549 Comparator | Jun 2023 → May 2025 | multiple sclerosis | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbial Transplants | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04150549 ↗ |
| Route | Oral | “Patients will be dosed with FMT oral capsules approximately 48 hours after antibiotic treatment has stopped.” NCT04150549 ↗ |